Send feedback

ASTN2 p.Arg232Ser

c.694C>A · VCV3954816

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.8679 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00181%, amr)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL no call

Computational evidence

Protein change
AlphaMissense0.8679likely pathogenic
REVEL0.362indeterminate
SaProtLLR -7.43tolerated
⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 2, phastCons 1
Regional constrainto/e 1.03unconstrained · MANE · 375 kb · p 0.43 · regional, not allelic
Overall
CADD25.5PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00181% Admixed American · 1/55,280 alleles
Filtering AF 2.9e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.1e-05%
Overall 0.000288% 4/1,389,534 alleles · very rare
Ancestry group Frequency 1 in
Admixed Americangrpmax 0.00181% 55,280
Remaining individualsnot grpmax-eligible 0.00169% 59,322
European (non-Finnish) 0.000176% 568,644

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ASTN2
Protein
p.Arg232Ser
Coding
c.694C>A
MANE Select
NM_001365068
Type
single nucleotide variant
Location
chr9:117214679 (GRCh38)
Gene constraint
LOEUF 0.473 · pLI 0.99 · ClinGen HI 1/3 (gnomAD)
Structure
AlphaFold pLDDT 64.93 · 3 PDB
Full ASTN2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/astn2-p-arg232ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown